Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety of Dapagliflozin in Combination With Metformin in Type 2 Diabetes Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Type 2 Diabetes~* Treated with oral anti-diabetic drug therapy therapy including Metformin for at least 8 weeks prior to enrolment~* HbA1c \>6.5% and \</=10%~Exclusion Criteria:~* Type 1 Diabetes~* Insulin therapy within one year of enrolment~* Renal (kidney) failure or dysfunction

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): dapagliflozin plus metformin
- 2 (Type: ACTIVE_COMPARATOR): glipizide plus metformin

Based on this trial design, predict the completion outcome and termination type (if applicable).